Aimei Health Technology Co. Ltd Ordinary Share (AFJK)

FairStock Score: 7/100 — RISKY

Key Financials

Strengths

• Generates $238,131 in annual free cash flow (0.1% yield on market cap)
• Altman Z-Score of 49.5 confirms minimal bankruptcy risk and strong solvency

Concerns

• Trades significantly above Graham Number ($5) with negative 815% margin of safety—limited downside protection
• Weak Piotroski F-Score of 1/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

Aimei Health Technology Co. Ltd Ordinary Share is a micro-cap financial services company valued at $287 million. From a quality standpoint, Aimei shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and Altman Z-Score of 49.5 confirms fortress-level solvency. On valuation, the stock is commanding a steep 241.2x multiple, with trades far above its Graham Number ($5) with no margin of safety. Growth dynamics show profit growth of -52.6%. Our composite FairStock Score of 7/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $238,131 in annual free cash flow (0.1% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

At 241x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer